SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 288 filers reported holding SEATTLE GENETICS INC in Q1 2018. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $169,571,000 | +79886.3% | 866,529 | +72110.8% | 0.08% | – |
| Q2 2020 | $212,000 | -98.2% | 1,200 | -99.3% | 0.00% | -100.0% |
| Q1 2019 | $11,967,000 | +29.3% | 163,400 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $9,258,000 | -26.5% | 163,400 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $12,601,000 | +75.1% | 163,400 | +50.7% | 0.01% | +50.0% |
| Q2 2018 | $7,197,000 | +26.8% | 108,400 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $5,674,000 | +3.6% | 108,400 | +5.9% | 0.00% | 0.0% |
| Q4 2017 | $5,478,000 | +25.8% | 102,400 | +28.0% | 0.00% | +50.0% |
| Q3 2017 | $4,353,000 | +88.7% | 80,000 | +118.0% | 0.00% | +100.0% |
| Q1 2017 | $2,307,000 | -80.9% | 36,699 | -86.7% | 0.00% | -83.3% |
| Q3 2013 | $12,054,000 | +25.0% | 275,030 | -10.3% | 0.01% | 0.0% |
| Q2 2013 | $9,644,000 | – | 306,530 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |